Fundraising FoxAgent Capital — 2025 Investments
7 investments dated 2025 · listed companies and verified rows first · show all
Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.
BiotechHealthtechLongevityPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)
Co-investorsAndera PartnersAvego BioScience CapitalGlobal BioAccess FundJeito CapitalKurma PartnersNew Rhein Healthcare Investors, LLC+2 more
Extracellular is a biomanufacturing company that helps cell-based product developers in cultivated meat, plant cell culture, and bioactives accelerate discovery, overcome production challenges, and commercialize their products.
Advanced ManufacturingBiotechFoodTechNew Materials
Will Milligan(CEO & Founder)in
Co-investorsBig Idea VenturesFFFNewland SyndicateUnruly Capital5AM VenturesCatalio Capital Management+8 more
GlycoEra develops glycan-based therapeutics, applying glycoengineering technology to create biologic drugs.
BiotechHealthtechNewton, US
Ganesh V. Kaundinya(President & CEO)in
Co-investors5AM VenturesCatalio Capital Management, LPLifeArc VenturesRoche Venture FundSixty Degree CapitalSofinnova Partners+1 more
Hone is an online clinic offering telehealth consultations, doctor-prescribed medications, and biomarker testing to help aging men and women manage their health.
Digital HealthLongevityMedia & EntertainmentWellness & Fitness
Alba Mertira(Founder)inSaad Alam(Founder)in
Co-investorsEarl Grey CapitalFJ LabsFlucas VenturesGaingelsGrowth Science Ventureshumbition+9 more
__Twitter.png)
Ivee provides AI training, strategy, and policy development services for organizational teams, including custom training programs, AI audits, policy writing, and tool integration guidance.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareFuture of WorkHR TechLondon, GB
Lydia Miller(Founder)inAmelia Miller(Founder)in
Co-investorsTechstarsFJ LabsGaingelshumbitionLooking Glass CapitalTribe Capital
A pharmaceutical company developing therapeutics across oncology, hematology, neuroscience, immunology, and cardiovascular disease with a pipeline of 50 compounds targeting 40+ disease areas.
BiotechHealthtechMedical Devices
Co-investorsAndreessen HorowitzARCH Venture PartnersiGlobe PartnersAlexandriaCasdin CapitalHeritage Medical Systems+5 more
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesViking Global+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.